American International Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

American International Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-59,801	Closed	-$1.12M	–	3389
2022 Q1	$1.12M	Sell	59,801 -4,210	-7%	-$75.8K	0.01%	1264
2021 Q4	$1.37M	Buy	64,011 +3,423	+6%	+$67.4K	0.01%	1239
2021 Q3	$1.12M	Buy	60,588 +11,001	+22%	+$222K	0.01%	1382
2021 Q2	$1.06K	Sell	49,587 -1,842	-4%	-$37.5K	﹤0.01%	1482
2021 Q1	$992	Buy	+51,429	New	+$906K	﹤0.01%	1462

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

American International Group's OCDX Position: Q2 2022 in Review

American International Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 59,801 shares — an estimated $1.12M sold.

American International Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $1.37M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

American International Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
American International Group sold 59,801 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.12M.
American International Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
American International Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.37M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.